ProShares UltraPro Dow30 ETF has 3X leverage, risks of drift in volatile markets, and is best suited for active traders, not ...

Lixte Biotechnology Holdings, Inc. (NASDAQ: LIXT) (the 'Company”), a clinical stage pharmaceutical company, today announced ...

Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that it has commenced an underwritten ...

For 1Q25, (Inst.) underperformed the Fund’s benchmark, the Russell 3000 Healthcare Index. Click here to read the full ...

Skin cancers are the most commonly diagnosed cancers in the United States, according to the National Center for Biotechnology ...

Research, Development and Innovation (RDI) scheme targets long-gestation, high-risk technologies via flexible capital routed ...

This is the Company's second granted patent for DMT410, using its Spongilla technology to topically deliver botulinum toxin for hyperhidrosis -- The Company recently entered into a Clinical Trial Coll ...

Sachin Dear Sachin, Bachelor of Business Administration (BBA) will provide a solid foundation for understanding business ...

A long-awaited report says companies are “simply inadequate at fully understanding” risks and harms.

Designed to be flexible and future-focused, these programmes incorporate NEP’s multiple-entry and exit options, allowing ...

Phytoform Labs is on a mission to shore up the nation’s food supplies using artificial intelligence (AI)-backed biotechnology, and the humble tomato.